Although the clinical application of HAND2-AS1 as a therapeutic target has not been assessed, based on the observed down-regulation of this lncRNA in a vast variety of tumors with different origins, up-regulation of HAND2-AS1 can be regarded as a therapeutic target for several types of cancer. This evidence concerns the gene HAND2 and cancer.